Analysis of Pfizer's U.S. Sales Force Restructuring
COMPLETED
This timely program provides valuable insight on how Pfizer reorganized its U.S. sales force. The key areas addressed in this study include:
 | New deployment of sales personnel by
division/force
| ||||||
| Restructuring of the sales organization
| ||||||
| Prioritization of the product portfolio by sales force | ||||||
| Attrition through restructuring
| ||||||
| Timeline for the reorganization | ||||||
| Key changes from old structure |
* Save 5% -- Mention "PharmCast.com" when purchase.
To receive more information about the study, including a list of companies analyzed and sample pages, click on the "Request for Info" link.
 |
| [
Outsourcing Guide
] [
Cont. Education
] [
Software/Reports
] [
Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ] [ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ] [ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ] [ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ] [ Site Map ] |